Index | FTSE 100 (EUR Hedged) |
Investment focus | Equity, United Kingdom |
Fund size | GBP 4 m |
Total expense ratio | 0.10% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | EUR |
Currency risk | Currency hedged |
Volatility 1 year (in GBP) | - |
Inception/ Listing Date | 21 August 2024 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | iShares |
Fund Structure | other |
UCITS compliance | Yes |
Administrator | State Street Fund Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Deloitte |
Fiscal Year End | 28 February |
Swiss representative | BlackRock Asset Management Schweiz AG |
Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
Germany | Unknown |
Switzerland | Unknown |
Austria | Unknown |
UK | Unknown |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
Securities lending | Yes |
Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
AstraZeneca PLC | 9.51% |
Shell Plc | 8.29% |
HSBC Holdings Plc | 5.95% |
Unilever Plc | 5.79% |
BP Plc | 3.51% |
RELX | 3.20% |
GSK Plc | 3.16% |
British American Tobacco plc | 2.69% |
Diageo Plc | 2.64% |
Rio Tinto Plc | 2.45% |
United Kingdom | 92.16% |
Switzerland | 2.60% |
Ireland | 1.88% |
Other | 3.36% |
Financials | 18.22% |
Consumer Staples | 17.15% |
Industrials | 13.79% |
Health Care | 13.50% |
Other | 37.34% |
YTD | - |
1 month | +0.24% |
3 months | - |
6 months | - |
1 year | - |
3 years | - |
5 years | - |
Since inception (MAX) | -0.47% |
2023 | - |
2022 | - |
2021 | - |
2020 | - |
Volatility 1 year | - |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | - |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | - |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -3.04% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
XETRA | EUR | CEB4 | - - | - - | - |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Core FTSE 100 UCITS ETF (Dist) | 13,937 | 0.07% p.a. | Distributing | Full replication |
Vanguard FTSE 100 UCITS ETF Distributing | 4,521 | 0.09% p.a. | Distributing | Full replication |
iShares Core FTSE 100 UCITS ETF GBP (Acc) | 2,738 | 0.07% p.a. | Accumulating | Full replication |
Vanguard FTSE 250 UCITS ETF Distributing | 2,603 | 0.10% p.a. | Distributing | Full replication |
Vanguard FTSE 100 UCITS ETF (GBP) Accumulating | 1,604 | 0.09% p.a. | Accumulating | Full replication |